Eli Lilly's $6B Alabama Plant: Trump's Drug Price Push
Birmingham News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Eli Lillys $6 billion manufacturing plant in Huntsville, Alabama, marks a significant investment in the state, following negotiations over prescription drug prices initiated by President Trumps executive order. The plant is a result of price concessions and commitments to invest in the U.S. However, concerns arise about potential government price controls that could impact the biotech sector. Alabama leaders advocate for free market changes to lower costs and maintain Americas edge in medical innovation.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/0393bf57fdc49340